Abstract
摘要
相似文献
1
Digibind and free digoxin.
Clin Chem. 1999 May;45(5):719-21.
2
Monitoring of unbound digoxin in patients treated with anti-digoxin antigen-binding fragments: a model for the future?
Clin Chem. 1998 Sep;44(9):1883-5.
3
4
Comparable effects of DIGIBIND and DigiFab in thirteen digoxin immunoassays.
Clin Chem. 2002 Sep;48(9):1580-4.
5
Problems in determining levels of free digoxin in patients treated with digoxin immune FAb.
J Clin Lab Anal. 1995;9(6):407-12. doi: 10.1002/jcla.1860090612.
6
Effects of digoxin immune Fab (ovine) on digoxin immunoassays.
Am J Clin Pathol. 1989 Dec;92(6):779-86. doi: 10.1093/ajcp/92.6.779.
7
Validity of unbound digoxin measurements by immunoassays in presence of antidote (Digibind).
Clin Chim Acta. 1999 May;283(1-2):159-69. doi: 10.1016/s0009-8981(99)00043-1.
8
[Treatment of severe digoxin intoxication with antidote].
Ugeskr Laeger. 2008 Oct 13;170(42):3339.
9
Effect of Brazilian, Indian, Siberian, Asian, and North American ginseng on serum digoxin measurement by immunoassays and binding of digoxin-like immunoreactive components of ginseng with Fab fragment of antidigoxin antibody (Digibind).
Am J Clin Pathol. 2005 Aug;124(2):229-36. doi: 10.1309/UTFT-K2LH-1RMH-CBD7.
10
Effect of digoxin fab antibody on the measurement of total and free digitoxin by fluorescence polarization and a new chemiluminescent immunoassay.
Ther Drug Monit. 1999 Apr;21(2):251-5. doi: 10.1097/00007691-199904000-00018.
Zotero 插件